Research Archive — Page 29 of 138

Kelly Dooley, MD, PhD, MPH. (photo by Susan Urmy)
September 11, 2024

Kelly Dooley’s TB research receives MERIT Award from the NIH  

Researchers must continually chase funding for their work. Kelly Dooley’s prestigious award from the NIH is intended to help provide respite from that chase.

September 9, 2024

Peptide discovery could advance treatment of high blood pressure

VUMC researchers found that peptides modified by highly reactive compounds called isolevuglandins activated T cells and promoted hypertension in mice. Their first-ever isolation of such peptides is a step toward potentially intervening in this pathologic process.

After connecting the dots between cognitive impairment and brain network organization in people diagnosed with psychotic disorders, researchers discovered the same link in those who hadn’t had their first psychotic episode.
September 4, 2024

Groundbreaking study links cognition and brain networks before the first psychotic break

Early detection opens the door to intervention via noninvasive neuromodulation for those with treatment-resistant symptoms of psychotic disorders like schizophrenia.

September 4, 2024

RSV vaccine in older people cuts risk of hospitalization

A multicenter study conducted in 19 states between October 2023 and March 2024 demonstrated that RSV vaccination was 75% effective in preventing RSV-associated hospitalizations for adults age 60 and older.

September 4, 2024

Bacterial metabolism plays role in staph antibiotic tolerance

Staph is a leading bacterial cause of death from bloodstream, bone and joint infections, in part because of high rates of antibiotic treatment failure.

(Adobe Stock)
August 29, 2024

Study finds human milk component may protect adult intestinal health

The research may lead to new treatments for diseases such as inflammatory bowel disease and mucositis, a severe complication of chemotherapy.